JPWO2023190663A1 - - Google Patents
Info
- Publication number
- JPWO2023190663A1 JPWO2023190663A1 JP2024512662A JP2024512662A JPWO2023190663A1 JP WO2023190663 A1 JPWO2023190663 A1 JP WO2023190663A1 JP 2024512662 A JP2024512662 A JP 2024512662A JP 2024512662 A JP2024512662 A JP 2024512662A JP WO2023190663 A1 JPWO2023190663 A1 JP WO2023190663A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022056754 | 2022-03-30 | ||
| PCT/JP2023/012761 WO2023190663A1 (ja) | 2022-03-30 | 2023-03-29 | 高純度化合物の製造方法および精製方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023190663A1 true JPWO2023190663A1 (https=) | 2023-10-05 |
| JPWO2023190663A5 JPWO2023190663A5 (https=) | 2026-04-03 |
Family
ID=88202044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024512662A Pending JPWO2023190663A1 (https=) | 2022-03-30 | 2023-03-29 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250214992A1 (https=) |
| EP (1) | EP4506347A4 (https=) |
| JP (1) | JPWO2023190663A1 (https=) |
| KR (1) | KR20240168375A (https=) |
| CN (1) | CN118946564A (https=) |
| TW (1) | TW202402753A (https=) |
| WO (1) | WO2023190663A1 (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3409237A1 (de) | 1984-03-14 | 1985-09-19 | Dr. Karl Thomae Gmbh, 7950 Biberach | Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE3626095A1 (de) * | 1986-07-31 | 1988-02-11 | Thomae Gmbh Dr K | Neue substituierte pyrido(2,3-b)(1,4)benzodiazepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US5716952A (en) | 1992-03-18 | 1998-02-10 | Allergan | Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists |
| JPH09318772A (ja) | 1996-05-28 | 1997-12-12 | Rhythm Watch Co Ltd | 装飾装置 |
| JP2017535545A (ja) * | 2014-11-21 | 2017-11-30 | ラボラトリオス・デル・デエレ・エステベ・エセ・ア | 疼痛に対する多様な活性を有するスピロ−イソキノリン−１，４’−ピペリジン化合物 |
| CN114302726A (zh) | 2020-08-04 | 2022-04-08 | 参天制药株式会社 | 用于治疗近视、预防近视及/或抑制近视发展的药剂 |
| JP7253813B2 (ja) | 2020-08-07 | 2023-04-07 | 株式会社ユニバーサルエンターテインメント | 遊技機 |
| WO2022080397A1 (ja) * | 2020-10-14 | 2022-04-21 | 参天製薬株式会社 | 安定な医薬組成物 |
| EP4501329A4 (en) * | 2022-03-30 | 2026-03-25 | Santen Pharmaceutical Co Ltd | METHOD FOR STERILIZING AND PACKAGING A PHARMACEUTICAL PREPARATION |
-
2023
- 2023-03-29 CN CN202380031604.XA patent/CN118946564A/zh active Pending
- 2023-03-29 TW TW112111992A patent/TW202402753A/zh unknown
- 2023-03-29 JP JP2024512662A patent/JPWO2023190663A1/ja active Pending
- 2023-03-29 EP EP23780672.4A patent/EP4506347A4/en active Pending
- 2023-03-29 WO PCT/JP2023/012761 patent/WO2023190663A1/ja not_active Ceased
- 2023-03-29 KR KR1020247035203A patent/KR20240168375A/ko active Pending
- 2023-03-29 US US18/851,293 patent/US20250214992A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4506347A4 (en) | 2026-03-25 |
| WO2023190663A1 (ja) | 2023-10-05 |
| US20250214992A1 (en) | 2025-07-03 |
| KR20240168375A (ko) | 2024-11-29 |
| CN118946564A (zh) | 2024-11-12 |
| TW202402753A (zh) | 2024-01-16 |
| EP4506347A1 (en) | 2025-02-12 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20241115 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260326 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20260326 |